Skip to content
Back to PTHS

Pelthos Therapeutics Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
26
Purchases
2
Sales
24
Purchase value
$999.98K
Sale value
$486.27K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Peter GreenleafDirector
4Rule 10b5-1 plan disclosed
Filed Oct 6, 2026Period of report Oct 2, 20260001919246-26-000131
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 2, 2026
Common StockF1797$21.17$16.87K23,087Direct
Filing footnotes · 1
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
Open on SEC EDGAR
Ezra M FriedbergDirector
4Rule 10b5-1 plan disclosed
Filed Oct 6, 2026Period of report Oct 2, 20260001919246-26-000130
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 2, 2026
Common StockF1558$20.7169$11.56K80,484Direct
Filing footnotes · 2
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Matthew PaulsDirector
4Rule 10b5-1 plan disclosed
Filed Oct 6, 2026Period of report Oct 2, 20260001919246-26-000129
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 2, 2026
Common StockF1786$21.00$16.51K13,578Direct
Filing footnotes · 1
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
Open on SEC EDGAR
Ezra M FriedbergDirector
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 2, 20260001919246-26-000102
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 2, 2026
Common StockF1F2534$26.0303$13.90K81,066Direct
SaleJul 2, 2026
Common StockF1F324$27.3254$655.8181,042Direct
Filing footnotes · 4
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $25.58 to $26.24. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $27.20 to $27.63. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. F4Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Matthew PaulsDirector
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 2, 20260001919246-26-000101
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 2, 2026
Common StockF1F2692$25.9959$17.99K14,458Direct
SaleJul 2, 2026
Common StockF1F394$27.3604$2.57K14,364Direct
Filing footnotes · 3
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $25.58 to $26.24. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $27.20 to $27.63. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Peter GreenleafDirector
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 2, 20260001919246-26-000100
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 2, 2026
Common StockF1F2712$25.9954$18.51K23,969Direct
SaleJul 2, 2026
Common StockF1F385$27.2733$2.32K23,884Direct
Filing footnotes · 3
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $25.58 to $26.53. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $27.20 to $27.63. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Ezra M FriedbergDirector
4Rule 10b5-1 plan disclosed
Filed Jun 17, 2026Period of report Jun 15, 20260001919246-26-000093
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Common StockF1F2224$27.1245$6.08K81,659Direct
SaleJun 15, 2026
Common StockF1F359$27.9403$1.65K81,600Direct
Filing footnotes · 4
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $26.71 to $27.44. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $27.92 to $28.00. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. F4Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Todd C DavisDirector
4
Filed Jun 15, 2026Period of report Jun 11, 20260001919246-26-000088
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseJun 11, 2026
Common StockF135,445$27.8046$985.53K75,331Direct
PurchaseJun 11, 2026
Common StockF2503$28.7261$14.45K75,834Direct
Filing footnotes · 3
  1. F1This transaction was executed in multiple trades at prices ranging from $27.63 to $28.49. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock purchased. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. F2This transaction was executed in multiple trades at prices ranging from $28.72 to $28.94. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock purchased. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3Todd Davis is the Chief Executive Officer and a member of the board of directors of Ligand Pharmaceuticals Inc. ("Ligand"). By virtue of this relationship, Mr. Davis may be deemed to beneficially own the shares of Common Stock held of record by Ligand. Mr. Davis disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Knuettel Francis IICFO, Treas & Secty
4
Filed May 26, 2026Period of report May 22, 20260001919246-26-000081
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 22, 2026
Common StockF3F41,500$26.8433$40.26K11,316IndirectBy Lara Knuettel Revocable Trust
Filing footnotes · 6
  1. F1Represents the forfeiture and cancellation of unvested restricted stock units ("RSUs") of Pelthos Therapeutics Inc. (the "Issuer"), for no consideration pursuant to that certain Separation Agreement entered into on May 15, 2026 (the "Separation Agreement") in connection with the reporting person's termination of employment as Chief Financial Officer of the Issuer.
  2. F2The Separation Agreement provides for the acceleration of vesting of 19,525 RSUs out of the 33,472 previously reported RSUs granted to the reporting person pursuant to the Issuer's 2023 Equity Incentive Plan, as amended from time to time (the "2023 Plan"), each of which represents the right to receive one (1) share of common stock, par value, $0.0001 per share ("Common Stock"), subject to the vesting terms of such RSUs, and may be settled solely in shares of Common Stock. The RSUs were received as compensation for the reporting person's service as an officer of the Issuer pursuant to the 2023 Plan. The 19,525 unvested RSUs became fully vested on May 22, 2026 upon expiration of the revocation period in the Separation Agreement. The transaction is exempt under Rule 16b-3(d). The acceleration does not represent a new grant of RSUs.
  3. F3Represents an open market sale of the Lara Knuettel Revocable (the "Trust") on May 22, 2026. This transaction was executed in multiple trades at prices ranging from $26.66 to $27.16. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected
  4. F4Francis Knuettel II is the co-trustee of the Trust and manager of Camden Capital LLC ("Camden"). By virtue of these relationships, Mr. Knuettel may be deemed to beneficially own the shares of Common Stock held of record by each of Camden and the Trust. Mr. Knuettel disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
  5. F5Represents the acceleration of vesting of stock options pursuant to the Separation Agreement in connection with the reporting person's termination of employment as Chief Financial Officer of the Issuer. The unvested stock options became fully vested and exercisable on May 22, 2026. The transaction is exempt under Rule 16b-3(d). This acceleration does not represent a new grant of options. The stock options may be exercised only until January 15, 2027, subject to the terms of the 2023 Plan and the Separation Agreement.
  6. F6Represents the forfeiture and cancellation of unvested stock options for no consideration pursuant to the Separation Agreement in connection with the reporting person's termination of employment as Chief Financial Officer of the Issuer.
Open on SEC EDGAR
Richard MalamutDirector
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001919246-26-000055
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common StockF1F2310$20.5126$6.36K27,702Direct
SaleApr 2, 2026
Common StockF1F3280$21.3612$5.98K27,422Direct
Filing footnotes · 3
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Ezra M FriedbergDirector
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001919246-26-000054
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common StockF1F2293$20.5121$6.01K82,292Direct
SaleApr 2, 2026
Common StockF1F3265$21.3612$5.66K82,027Direct
Filing footnotes · 4
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. F4Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Open on SEC EDGAR
Matthew PaulsDirector
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001919246-26-000053
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common StockF1F2415$20.5154$8.51K15,521Direct
SaleApr 2, 2026
Common StockF1F3371$21.3628$7.93K15,150Direct
Filing footnotes · 3
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Peter GreenleafDirector
4Rule 10b5-1 plan disclosed
Filed Apr 6, 2026Period of report Apr 2, 20260001919246-26-000052
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common StockF1F2420$20.5151$8.62K25,058Direct
SaleApr 2, 2026
Common StockF1F3377$21.3614$8.05K24,681Direct
Filing footnotes · 3
  1. F1This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer.
  2. F2This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. F3This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Open on SEC EDGAR
Ezra M FriedbergDirector
4
Filed Nov 26, 2025Period of report Nov 25, 20250001753926-25-001831
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 25, 2025
Common StockF15,999$28.00$167.97K34,001IndirectBy Balmoral Financial Group LLC
SaleNov 25, 2025
Common StockF12,000$28.135$56.27K32,001IndirectBy Balmoral Financial Group LLC
SaleNov 25, 2025
Common StockF11$28.50$28.5032,000IndirectBy Balmoral Financial Group LLC
SaleNov 25, 2025
Common StockF12,000$28.005$56.01K30,000IndirectBy Balmoral Financial Group LLC
Filing footnotes · 1
  1. F1Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.